Michelle Futrell, director of lung cancer screening programs and initiatives at the LUNGevity Foundation, joins Tony Riggsbee to discuss why only 25% of eligible Americans are getting screened for lung cancer despite screening reducing the risk of death from the disease by 20%, and what patients should know about eligibility guidelines, misconceptions and biomarker testing after a diagnosis. For more information visit lungevity.org.